Natera Inc (NASDAQ:NTRA) — Market Cap & Net Worth
Market Cap & Net Worth: Natera Inc (NTRA)
Natera Inc (NASDAQ:NTRA) has a market capitalization of $28.77 Billion ($28.77 Billion) as of May 2, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #912 globally and #388 in its home market, demonstrating a 3.05% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Natera Inc's stock price $207.28 by its total outstanding shares 141731250 (141.73 Million). Analyse Natera Inc (NTRA) cash flow conversion to see how efficiently the company converts income to cash.
Natera Inc Market Cap History: 2015 to 2026
Natera Inc's market capitalization history from 2015 to 2026. Data shows growth from $1.53 Billion to $29.38 Billion (35.34% CAGR).
Index Memberships
Natera Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
ARCA Biotechnology
BTK
|
$910.33 Billion | 3.16% | #8 of 30 |
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 1.19% | #11 of 976 |
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.07% | #109 of 3165 |
Weight: Natera Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Natera Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Natera Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
14.08x
Natera Inc's market cap is 14.08 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.66 Billion | $217.07 Million | -$95.77 Million | 7.65x | N/A |
| 2017 | $1.27 Billion | $210.94 Million | -$136.31 Million | 6.04x | N/A |
| 2018 | $1.98 Billion | $257.65 Million | -$128.15 Million | 7.68x | N/A |
| 2019 | $4.77 Billion | $302.33 Million | -$124.83 Million | 15.79x | N/A |
| 2020 | $14.11 Billion | $391.00 Million | -$229.74 Million | 36.07x | N/A |
| 2021 | $13.24 Billion | $625.49 Million | -$471.72 Million | 21.16x | N/A |
| 2022 | $5.69 Billion | $820.22 Million | -$547.80 Million | 6.94x | N/A |
| 2023 | $8.88 Billion | $1.08 Billion | -$434.80 Million | 8.20x | N/A |
| 2024 | $22.44 Billion | $1.70 Billion | -$190.43 Million | 13.22x | N/A |
| 2025 | $32.47 Billion | $2.31 Billion | -$208.16 Million | 14.08x | N/A |
Competitor Companies of NTRA by Market Capitalization
Companies near Natera Inc in the global market cap rankings as of May 2, 2026.
Key companies related to Natera Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #126 globally with a market cap of $176.29 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $123.72 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #578 globally with a market cap of $45.31 Billion USD.
- LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #643 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #126 | Thermo Fisher Scientific Inc | NYSE:TMO | $176.29 Billion | $469.21 |
| #189 | Danaher Corporation | NYSE:DHR | $123.72 Billion | $175.15 |
| #578 | IDEXX Laboratories Inc | NASDAQ:IDXX | $45.31 Billion | $567.46 |
| #643 | LONZA GROUP UNSP.ADR 1/10 | F:LO3A | $41.04 Billion | €54.50 |
Natera Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Natera Inc's market cap moved from $1.53 Billion to $ 29.38 Billion, with a yearly change of 35.34%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $29.38 Billion | -9.52% |
| 2025 | $32.47 Billion | +44.72% |
| 2024 | $22.44 Billion | +152.71% |
| 2023 | $8.88 Billion | +55.94% |
| 2022 | $5.69 Billion | -56.99% |
| 2021 | $13.24 Billion | -6.16% |
| 2020 | $14.11 Billion | +195.40% |
| 2019 | $4.77 Billion | +141.33% |
| 2018 | $1.98 Billion | +55.28% |
| 2017 | $1.27 Billion | -23.23% |
| 2016 | $1.66 Billion | +8.43% |
| 2015 | $1.53 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Natera Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $28.77 Billion USD |
| MoneyControl | $28.77 Billion USD |
| MarketWatch | $28.77 Billion USD |
| marketcap.company | $28.77 Billion USD |
| Reuters | $28.77 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Natera Inc
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehe… Read more